Reflect on the provided data and tweets to anticipate if the closing price of $amgn is going to increase or decrease at 2014-01-10. Kindly respond with either Rise or Fall.
Context: date,open,high,low,close,adj-close,inc-5,inc-10,inc-15,inc-20,inc-25,inc-30
2013-12-26,-1.5,0.1,-1.7,1.9,1.9,-0.9,-1.4,-1.2,-1.0,-0.9,-0.7
2013-12-27,-0.2,0.3,-0.7,0.7,0.7,-1.2,-1.9,-1.7,-1.6,-1.6,-1.3
2013-12-30,-0.1,0.0,-1.0,0.3,0.3,-1.2,-1.9,-1.9,-1.8,-1.8,-1.6
2013-12-31,1.6,1.6,-0.4,-1.2,-1.2,0.2,-0.5,-0.7,-0.6,-0.5,-0.4
2014-01-02,-1.2,0.3,-1.5,1.5,1.5,-0.7,-1.6,-2.1,-2.0,-1.9,-1.9
2014-01-03,1.1,1.3,-0.4,-1.1,-1.1,0.5,-0.3,-0.9,-0.8,-0.8,-0.8
2014-01-06,0.9,1.3,-0.3,-0.9,-0.9,1.0,0.7,0.0,0.0,0.1,0.0
2014-01-07,-2.5,0.3,-2.7,2.6,2.6,-1.4,-1.7,-2.2,-2.4,-2.4,-2.4
2014-01-08,0.7,0.9,-0.5,-0.5,-0.5,-0.6,-1.0,-1.6,-1.8,-1.9,-1.8
2014-01-09,-2.0,0.1,-2.2,2.6,2.6,-2.6,-2.9,-3.6,-4.1,-4.2,-4.2

2014-01-02: rt AT_USER impressive data from $amgn and ucb with romosozumab (anti-sclerostin) in osteoporosis, published today in AT_USER 
2014-01-08: rt AT_USER ubs key events: $celg $gild $biib $amgn $regn |$xncr is eligible for up to $1.3b milestone paymts from partnerships w $mor $amgn $alxn $jnj $csl.ax $mrk bi[wedbush] |s&amp;p100 #stocks tren
2014-01-09: $amgn - amgen vs. merck, lilly in osteoporosis competition -&gt;  #stock #stocks #stockaction
Answer:
Fall